MALDI-TOF MS and TaqMan® assisted SNP genotyping of DNA isolated from formalin-fixed and paraffin-embedded tissues (FFPET)

被引:39
作者
Jaremko, M
Justenhoven, C
Abraham, BK
Schroth, W
Fritz, P
Brod, S
Vollmert, C
Illig, T
Brauch, H
机构
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany
[2] GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, Neuherberg, Germany
关键词
formalin-fixed paraffin-embedded tissue; SNP; genotyping; MALDI-TOFMS; TaqMan; mutation detection;
D O I
10.1002/humu.20141
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学]; 090102 [作物遗传育种];
摘要
Formalin-fixed paraffin, embedded tissues (FFPET) from archived clinical samples provide an invaluable source for large-scale molecular genetic studies. Pharmacogenetic investigations that require long,term clinical follow-up data of patients may particularly benefit from FFPET analysis. Matrix assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and TaqMan(C)-based (Thermus aquaticus polymerase) methodologies have become standard genotyping procedures. However, no data are available on the applicability of MALDI-TOF MS to the genotyping of low quality DNA, as it is usually obtained from FFPET, and data from TaqMan genotyping are limited. We isolated constitutional DNA from 274 FFPET samples (229 patients with breast cancer and 45 patients with benign breast diseases) and genotyped 15 polymorphic loci in 10 genes. Nine SNPs were genotyped by MALDI-TOF MS, and six were genotyped by the TaqMan methodology. We established rates for successful allele assignment for all FFPET, for FFPET prepared prior to 1990, and for FFPET prepared post,1990. Both methodologies showed high success rates ranging between 70.9 and 99.6% (mean: 91.8%) for MALDI-TOF MS and between 82.3 and 97.7% (mean: 91.0%) for TaqMan genotyping. No significant differences in genotyping performances for FFPET prepared prior to 1990 or post-1990 were observed. With the exception of one, all other genotype frequencies were in Hardy-Weinberg equilibrium. Furthermore, genotype frequencies matched those observed in a German breast cancer population and other Caucasian populations. Our study shows for the first time that MALDI-TOF MS and TaqMan genotyping procedures provide reliable data, and are therefore applicable in studies that require large scale FFPET genotyping. (C) 2005 Wiley,Liss, Inc.
引用
收藏
页码:232 / 238
页数:7
相关论文
共 36 条
[1]
Bailey LR, 1998, CANCER RES, V58, P5038
[2]
Bailey LR, 1998, CANCER RES, V58, P65
[3]
BENEZRA J, 1991, J HISTOCHEM CYTOCHEM, V39, P351, DOI 10.1177/39.3.1704393
[4]
VHL mutations in renal cell cancer:: does occupational exposure to trichloroethylene make a difference? [J].
Brauch, H ;
Weirich, G ;
Klein, B ;
Rabstein, S ;
Bolt, HM ;
Brüning, T .
TOXICOLOGY LETTERS, 2004, 151 (01) :301-310
[5]
Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene [J].
Brogan, IJ ;
Khan, N ;
Isaac, K ;
Hutchinson, JA ;
Pravica, V ;
Hutchinson, IV .
HUMAN IMMUNOLOGY, 1999, 60 (12) :1245-1249
[6]
Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer [J].
Campbell, IG ;
Baxter, SW ;
Eccles, DM ;
Choong, DYH .
BREAST CANCER RESEARCH, 2002, 4 (06)
[7]
Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects [J].
Cascorbi, I ;
Gerloff, T ;
Johne, A ;
Meisel, C ;
Hoffmeyer, S ;
Schwab, M ;
Schaeffeler, E ;
Eichelbaum, M ;
Brinkmann, U ;
Roots, I .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :169-174
[8]
Loss of heterozygosity studies revisited - Prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability [J].
Farrand, K ;
Jovanovic, L ;
Delahunt, B ;
McIver, B ;
Hay, ID ;
Eberhardt, NL ;
Grebe, SKG .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2002, 4 (03) :150-158
[9]
Försti A, 2004, ONCOL REP, V11, P917
[10]
Garte S, 2001, CANCER EPIDEM BIOMAR, V10, P1239